Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00569894 · ClinicalTrials.gov registry record

A Post Marking Study to Evaluate the Safety of FluMist in Children

A clinical trial, sponsored by MedImmune.

Completed
Registry status
29,296
Enrollment target

NCT00569894 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 29,296 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00569894 has completed, sponsored by MedImmune.

COMPLETED
Registry status
29,296 participants
Enrollment target

Study Summary

To assess the safety of FluMist vaccination

Interventions

  • BIOLOGICAL FLuMist
  • BIOLOGICAL TIV (Injection)
  • OTHER Unvaccinated Control

Trial Details

FieldValue
Enrollment Target 29,296 participants
Start Date 2007-10
Est. Completion 2011-06

Sponsor

MedImmune

210 total trials

What the Registry Record Tells You About NCT00569894

The ClinicalTrials.gov registry entry for NCT00569894 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29,296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which FLuMist is the first listed.

NCT00569894 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00569894 about?

NCT00569894 is a clinical study titled "A Post Marking Study to Evaluate the Safety of FluMist in Children". To assess the safety of FluMist vaccination

What is the current status of trial NCT00569894?

This trial is currently completed. The enrollment target is 29,296 participants. The study started on 2007-10. Estimated completion is 2011-06.

What interventions are being tested in trial NCT00569894?

The interventions under investigation include: FLuMist (BIOLOGICAL), TIV (Injection) (BIOLOGICAL), Unvaccinated Control (OTHER).

Who is sponsoring clinical trial NCT00569894?

This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.